305 related articles for article (PubMed ID: 24905852)
1. Infantile haemangiomas that failed treatment with propranolol: clinical and histopathological features.
Phillips RJ; Lokmic Z; Crock CM; Penington A
J Paediatr Child Health; 2014 Aug; 50(8):619-25. PubMed ID: 24905852
[TBL] [Abstract][Full Text] [Related]
2. Mast cells as possible targets of propranolol therapy: an immunohistological study of beta-adrenergic receptors in infantile haemangiomas.
Prey S; Leaute-Labreze C; Pain C; Moisan F; Vergnes P; Loot M; Taieb A; Cario-Andre M
Histopathology; 2014 Sep; 65(3):436-9. PubMed ID: 24666350
[No Abstract] [Full Text] [Related]
3. Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients.
Thoumazet F; Léauté-Labrèze C; Colin J; Mortemousque B
Br J Ophthalmol; 2012 Mar; 96(3):370-4. PubMed ID: 21673014
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
Léauté-Labrèze C; Taïeb A
Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
[No Abstract] [Full Text] [Related]
5. Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report.
Cloke A; Lim LT; Blaikie A
Semin Ophthalmol; 2013 Jan; 28(1):32-3. PubMed ID: 23305438
[TBL] [Abstract][Full Text] [Related]
6. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
Holmes WJ; Mishra A; Gorst C; Liew SH
J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
[TBL] [Abstract][Full Text] [Related]
7. Severe infantile haemangioma: complications and treatment.
Heaton P; Kennedy C; Amin S
J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
[No Abstract] [Full Text] [Related]
8. Propranolol for infantile haemangiomas: single centre experience of 250 cases and proposed therapeutic protocol.
Solman L; Murabit A; Gnarra M; Harper JI; Syed SB; Glover M
Arch Dis Child; 2014 Dec; 99(12):1132-6. PubMed ID: 25123404
[TBL] [Abstract][Full Text] [Related]
9. [Propranolol therapy for periocular and orbital infantile haemangiomas].
Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
[TBL] [Abstract][Full Text] [Related]
10. Propranolol for complicated infantile haemangiomas: a case series of 30 infants.
Manunza F; Syed S; Laguda B; Linward J; Kennedy H; Gholam K; Glover M; Giardini A; Harper JI
Br J Dermatol; 2010 Feb; 162(2):466-8. PubMed ID: 20055816
[No Abstract] [Full Text] [Related]
11. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
12. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of infantile hemangioma after termination of propranolol treatment.
Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of infantile haemangiomas of the orbit with propranolol.
Li YC; McCahon E; Rowe NA; Martin PA; Wilcsek GA; Martin FJ
Clin Exp Ophthalmol; 2010 Aug; 38(6):554-9. PubMed ID: 20491798
[TBL] [Abstract][Full Text] [Related]
15. High levels of β2-adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol.
Hadaschik E; Scheiba N; Engstner M; Flux K
J Cutan Pathol; 2012 Sep; 39(9):881-3. PubMed ID: 22764832
[No Abstract] [Full Text] [Related]
16. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
17. Distribution of problematic localized facial infantile haemangiomas and their response to propranolol: a retrospective cohort study.
Chang L; Chen Q; Zhou L; Chang SJ; Gao W; Yu Z; Chen J; Li H; Qiu Y; Lin X
Clin Exp Dermatol; 2023 Mar; 48(3):193-198. PubMed ID: 36763678
[TBL] [Abstract][Full Text] [Related]
18. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
[TBL] [Abstract][Full Text] [Related]
19. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
20. Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.
Dyme JL; Thampan A; Han EJ; Nyirenda TL; Kotb ME; Shin HT
Cardiol Young; 2012 Aug; 22(4):424-9. PubMed ID: 22166728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
